Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-24 @ 5:38 PM
NCT ID:
NCT02363868
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
* Age \>18 years
* International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM) code for CML (205.1x)
* At least 2 prescriptions for dasatinib or nilotinib from July 1, 2008 to June 31, 2013
* Continuous eligibility for the 6 months pre- and post-index date (defined as the date of first fill for dasatinib or nilotinib)
Exclusion Criteria:
* History of bone marrow or stem cell transplant as identified in the 6 month pre-period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02363868
Study Brief:
Protocol Section:
NCT02363868